Inspite of being made for under $5 per month, copyright carries a retail selling price that's hard to justify. The numerous hole amongst output expenditures and pricing raises important questions on the pharmaceutical sector's pricing tactics.California biotech behemoth Amgen ditched designs for an experimental weight loss capsule in May but is sti